Study Overview: This research is testing a new treatment for people with certain advanced cancers. It uses two medications: TAB004 and toripalimab, both are types of monoclonal antibodies. These are special proteins that can help the immune system attack cancer cells. The study will check how safe these medicines are when used alone or together, and how they behave in the body (called pharmacokinetics).
Key Points:
- Study Length: If you join, you might receive treatment every 21 days for up to 2 years.
- Participation Requirements: You must be 18 or older with certain advanced cancers and meet other health criteria.
- Visits and Evaluations: Regular visits will include tests like blood work and imaging to monitor your health and the treatment's effects.
This study may help researchers find better treatments for cancer, but it also has risks, like possible side effects from the medications. Participants will be closely monitored for any adverse reactions. If you're considering joining, discuss it with your doctor to understand the benefits and risks.
How understandable was the trial content above?
Hard to understand
Easy to understand